Company news

Neovasc Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Neovasc Announces Circulatory System Devices Panel Meeting Date for Neovasc Reducer(TM) Device

July 9, 2020

Neovasc Provides Update on Second Quarter Results

July 6, 2020

Neovasc Reducer(TM) and Tiara(TM) Featured at Leading Industry Virtual Conferences

June 29, 2020

Neovasc Announces Positive Interim Results from REDUCER-I Study

June 26, 2020

Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule

June 25, 2020

Neovasc Announces Closing of $11.5 Million Registered Direct Offering Priced At-The-Market

June 16, 2020

Neovasc Announces $11.5 Million Registered Direct Offering Priced At-The-Market

June 12, 2020

Neovasc Reducer(TM) and Tiara(TM) Program to be Highlighted at Leading Industry Virtual Conferences

June 9, 2020

Neovasc Announces Closing of Final Convertible Debt Issuance for Gross Proceeds of US$5.0 Million

June 4, 2020

Neovasc Reducer Spotlighted in Leading German Public Television Program

June 3, 2020

Neovasc Has Filed for CE Mark for Tiara TA Transapical Mitral Valve Replacement System

May 27, 2020

Neovasc Provides Corporate Update

May 26, 2020

Neovasc Announces Offering of Convertible Debt and Warrants for Gross Proceeds of up to US$5.0 Million, Warrant Exchange Transaction and Repayment of 2017 Convertible Notes and Related Settlement

May 26, 2020

Neovasc Announces First Quarter Financial Results

May 7, 2020

Neovasc Announces Receipt of Nasdaq Extension to Satisfy Market Cap Rule

May 1, 2020

Neovasc to Report First Quarter Financial Results on May 7, 2020

April 23, 2020

Neovasc Announces Fourth Quarter and Full Year 2019 Financial Results

March 30, 2020

Neovasc to Report Fourth Quarter and Full Year 2019 Financial Results on March 30, 2020

March 17, 2020

Neovasc Updates Investors at SVB Leerink 9th Annual Global Healthcare Conference

March 4, 2020

Neovasc Reducer Featured in Peer Reviewed EuroIntervention and PCR Online

March 3, 2020

Neovasc Will Request Nasdaq Hearing After Company Received Expected Delisting Determination From Nasdaq Staff

February 20, 2020

Neovasc to Participate in SVB Leerink 9th Annual Global Healthcare Conference on February 26, 2020

February 18, 2020

Neovasc Achieves Design Freeze for Transfemoral Trans-septal Tiara(TM) Mitral Valve System

February 12, 2020

Neovasc Initiates Independent Inquiry into Trading of Its Shares

February 11, 2020

Neovasc Provides Update on Nasdaq Compliance

February 3, 2020

Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer(TM) for Treatment of Refractory Angina

January 31, 2020

Neovasc Announces Executive Steering Committee for Transfemoral Trans-Septal Tiara Program

January 28, 2020

Neovasc Advances New Transfemoral Trans-Septal Tiara Design Concept After Further Successful Tests

January 24, 2020

Neovasc Reducer(TM) for Treatment of Refractory Angina Featured in Multiple Presentations in Germany

January 22, 2020

Updates on Reducer and Tiara Programs Will be Presented at Advanced Cardiovascular Intervention 2020 Meeting

January 21, 2020

Neovasc Receives Administrative Acceptance Review Notification for Premarket Approval Application from FDA for the Neovasc Reducer(TM)

January 15, 2020

Neovasc Inc. Investor Update

January 13, 2020

Neovasc Announces Closing of $10 Million Registered Direct Offering Priced At-The-Market

January 6, 2020

Neovasc Announces $10 Million Registered Direct Offering Priced At-The-Market

January 2, 2020

Neovasc Submits Premarket Approval Application to FDA for Neovasc Reducer(TM)

December 31, 2019

Neovasc Reducer(TM) Featured In National Geographic Magazine

December 17, 2019

Neovasc Named Finalist in Questex's Fierce Innovation Awards Lifesciences Edition 2019

December 4, 2019

Neovasc Reducer(TM) Featured In FOCUS Magazine

November 26, 2019

Neovasc Reducer(TM) Featured During Therapy Development Program in Coburg and Session at Maria Cecilia Hospital in Cotignola

November 22, 2019

Neovasc Tiara(TM) Progress Highlighted at PCR London Valves 2019

November 19, 2019

Neovasc Reducer(TM) Therapy for Refractory Angina Exceeds 200th Patient Milestone in Germany

November 12, 2019

Neovasc Announces Third Quarter 2019 Financial Results

November 7, 2019

Neovasc to Participate in Stifel 2019 Healthcare Conference and Cannacord Genuity 13th Annual MedTech & Diagnostics Forum

November 6, 2019

Neovasc to Provide Update on TF/TS Tiara Program at PCR Valves 2019

November 5, 2019

Neovasc to Submit Full PMA Application for Neovasc Reducer(TM) in 2019

November 1, 2019

Neovasc to Participate in the 28th Annual Credit Suisse Healthcare Conference on Wednesday, November 13, 2019

October 30, 2019

Neovasc to Announce Third Quarter 2019 Financial Results on Thursday, November 7, 2019

October 25, 2019

Neovasc Reducer(TM) for Treatment of Refractory Angina Featured in Sponsored Session at the 40th Annual National Congress of the Italian Society of Interventional Cardiology

October 22, 2019

Neovasc Retains Westwicke, ICR for Integrated Communications Counsel

October 16, 2019

Neovasc Announces Notice of US Patent Granted for Tiara(TM) Transcatheter Device for Treatment of Severe Mitral Regurgitation

October 15, 2019

← Newer news releases · Older news releases →

Decks

The 5 newest of 13 decks. Every deck is listed under its year.